Hirokazu Oguni

6.2k total citations
144 papers, 3.6k citations indexed

About

Hirokazu Oguni is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Hirokazu Oguni has authored 144 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Psychiatry and Mental health, 54 papers in Pediatrics, Perinatology and Child Health and 39 papers in Cellular and Molecular Neuroscience. Recurrent topics in Hirokazu Oguni's work include Epilepsy research and treatment (103 papers), Pharmacological Effects and Toxicity Studies (39 papers) and Neuroscience and Neuropharmacology Research (37 papers). Hirokazu Oguni is often cited by papers focused on Epilepsy research and treatment (103 papers), Pharmacological Effects and Toxicity Studies (39 papers) and Neuroscience and Neuropharmacology Research (37 papers). Hirokazu Oguni collaborates with scholars based in Japan, Pakistan and Italy. Hirokazu Oguni's co-authors include Makiko Ōsawa, Kitami Hayashi, Yukio Fukuyama, Charlotte Dravet, Makoto Funatsuka, Kaoru S. Imai, Shinichi Hirose, Yutaka Awaya, Masako Sakauchi and Yasushi Ito and has published in prestigious journals such as PLoS ONE, Neurology and Annals of Neurology.

In The Last Decade

Hirokazu Oguni

138 papers receiving 3.5k citations

Peers

Hirokazu Oguni
Roberto Caraballo Argentina
Anna Kamińska France
Perrine Plouin France
Raili Riikonen Finland
W.O. Renier Netherlands
Charlotte Dravet Italy
Laura Maria de Figueiredo Ferreira Guilhoto Brazil
Yushi Inoue Japan
Natalio Fejerman Argentina
Sara Kivity Israel
Roberto Caraballo Argentina
Hirokazu Oguni
Citations per year, relative to Hirokazu Oguni Hirokazu Oguni (= 1×) peers Roberto Caraballo

Countries citing papers authored by Hirokazu Oguni

Since Specialization
Citations

This map shows the geographic impact of Hirokazu Oguni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirokazu Oguni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirokazu Oguni more than expected).

Fields of papers citing papers by Hirokazu Oguni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirokazu Oguni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirokazu Oguni. The network helps show where Hirokazu Oguni may publish in the future.

Co-authorship network of co-authors of Hirokazu Oguni

This figure shows the co-authorship network connecting the top 25 collaborators of Hirokazu Oguni. A scholar is included among the top collaborators of Hirokazu Oguni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirokazu Oguni. Hirokazu Oguni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kubota, Yuichi, et al.. (2022). Non-lesional late-onset epilepsy in the elderly Japanese patients: Presenting characteristics and seizure outcomes with regard to comorbid dementia. Journal of Clinical Neuroscience. 103. 100–106. 7 indexed citations
2.
Ito, Susumu, et al.. (2021). Low-dose phenobarbital for epilepsy with myoclonic absences: A case report. Brain and Development. 43(5). 666–668. 3 indexed citations
3.
4.
Fukuyama, Tetsuhiro, Yukitoshi Takahashi, Yuko Kubota, et al.. (2015). Semi-quantitative analyses of antibodies to N-methyl-d-aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome. Epilepsy Research. 113. 34–43. 16 indexed citations
5.
6.
Ito, Susumu, Hirokazu Oguni, & Makiko Ōsawa. (2012). Benign myoclonic epilepsy in infancy with preceding afebrile generalized tonic–clonic seizures in Japan. Brain and Development. 34(10). 829–833. 4 indexed citations
7.
Liang, Jao‐Shwann, Keiko Shimojima, Rumiko Takayama, et al.. (2011). CDKL5 alterations lead to early epileptic encephalopathy in both genders. Epilepsia. 52(10). 1835–1842. 58 indexed citations
8.
Oguni, Hirokazu, Jao‐Shwann Liang, Hiroko Ikeda, et al.. (2010). STXBP1 mutations cause not only Ohtahara syndrome but also West syndrome—Result of Japanese cohort study. Epilepsia. 51(12). 2449–2452. 79 indexed citations
9.
Shimojima, Keiko, Yuta Komoike, Jun Tohyama, et al.. (2009). TULIP1 (RALGAPA1) haploinsufficiency with brain development delay. Genomics. 94(6). 414–422. 33 indexed citations
10.
Hirano, Yoshiko, Hirokazu Oguni, & Makiko Ōsawa. (2008). Clinical factors related to treatment resistance in juvenile myoclonic epilepsy. Rinsho Shinkeigaku. 48(10). 727–732. 4 indexed citations
11.
Oguni, Hirokazu, et al.. (2008). Symptomatic Parieto-Occipital Epilepsy as Sequela of Perinatal Asphyxia. Pediatric Neurology. 38(5). 345–352. 16 indexed citations
12.
Ito, Susumu, et al.. (2008). Agranulocytosis following phenytoin-induced hypersensitivity syndrome. Brain and Development. 31(6). 449–451. 7 indexed citations
13.
Oguni, Hirokazu, et al.. (2005). 周産期の軽度低酸素性虚血性脳症(HIE)による頭頂後頭葉てんかん症候群(SPOE)の臨床分析. Epilepsia. 46. 226. 8 indexed citations
14.
Fukuma, Goryu, Hirokazu Oguni, Yukiyoshi Shirasaka, et al.. (2004). Mutations of Neuronal Voltage‐gated Na+ Channel α1 Subunit Gene SCN1A in Core Severe Myoclonic Epilepsy in Infancy (SMEI) and in Borderline SMEI (SMEB). Epilepsia. 45(2). 140–148. 161 indexed citations
15.
Oguni, Hirokazu, et al.. (2002). Clinical and EEG analysis of initial status epilepticus during infancy in patients with mesial temporal lobe epilepsy. Brain and Development. 24(4). 231–238. 3 indexed citations
16.
Oguni, Hirokazu, Teruyuki Tanaka, Keiko Hayashi, et al.. (2002). Treatment and Long-Term Prognosis of Myoclonic-Astatic Epilepsy of Early Childhood. Neuropediatrics. 33(3). 122–132. 116 indexed citations
17.
18.
19.
Oguni, Hirokazu, et al.. (2000). Successful Trial of Amantadine Hydrochloride for Two Patients with Alternating Hemiplegia of Childhood. Neuropediatrics. 31(6). 307–309. 10 indexed citations
20.
Oguni, Hirokazu & Yukio Fukuyama. (1989). A clinical and electroencephalographic study of myoclonic epilepsies in infancy and early childhood. Part 1. On the classification.. Journal of the Japan Epilepsy Society. 7(1). 67–76. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberto Caraballo Breakdown of academic impact, for papers by Anna Kamińska Breakdown of academic impact, for papers by Perrine Plouin Breakdown of academic impact, for papers by Raili Riikonen Breakdown of academic impact, for papers by W.O. Renier Breakdown of academic impact, for papers by Charlotte Dravet Breakdown of academic impact, for papers by Laura Maria de Figueiredo Ferreira Guilhoto Breakdown of academic impact, for papers by Yushi Inoue Breakdown of academic impact, for papers by Natalio Fejerman Breakdown of academic impact, for papers by Sara Kivity
Rankless by CCL
2026